Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

Completed · Phase 1

Conditions studied: Healthy

In brief

To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)

Key facts

Study ID

NCT00662883

Run by

Javelin Pharmaceuticals

People needed

18

Starts

2007-11-01

Expected to finish

2008-02-01

Last updated by the study team

2008-04-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adults
• nonsmoker
• no drug use

You may not qualify if…

• nasal abnormalities
• airway abnormalities

Where it is running

• Study site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.